SCHEMBL1941256

SCHEMBL1941256

CN(C)CCCNCC(=O)NC(Sc1ncccc1C(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccncc1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.46
KMT2A Q03164 2/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
KDR P35968 7/20 0.46
KDM4E B2RXH2 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
ABL1 P00519 4/20 0.40
ALDH1A1 P00352 1/20 0.40
FLT1 P17948 5/20 0.39
TRPV1 Q8NER1 1/20 0.37
HTR2C P28335 1/20 0.37
MCHR2 Q969V1 1/20 0.37
MCHR1 Q99705 1/20 0.37
NTRK1 P04629 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1940711 0.96 MAPT (0.48) MAPTKMT2ACRHBPCRHR2KDR
SCHEMBL1941600 0.93 KDR (0.49) MAPTKMT2ACRHBPCRHR2KDR
SCHEMBL3931741 0.91 MAPT (0.48) MAPTKMT2ACRHBPCRHR2KDR
SCHEMBL1940765 0.91 KDR (0.50) MAPTKMT2ACRHBPCRHR2KDR
SCHEMBL1941133 0.89 MAPT (0.53) MAPTKMT2ACRHBPCRHR2KDR
SCHEMBL1939946 0.88 MAPT (0.51) MAPTKMT2ACRHBPCRHR2KDR
SCHEMBL3922954 0.88 KDR (0.49) KMT2AKDRKDM4ETDP1ALDH1A1
SCHEMBL1940549 0.88 KDR (0.51) MAPTKMT2ACRHBPCRHR2KDR
SCHEMBL3935942 0.88 KDR (0.47) MAPTKMT2ACRHBPCRHR2KDR
SCHEMBL1943221 0.88 MAPT (0.49) MAPTKMT2ACRHBPCRHR2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1717229-B1 NOVEL CYCLIC COMPOUND HAVING 4-PYRIDYLALKYLTHIO GROUP HAVING (UN)SUBSTITUTED AMINO INTRODUCED THEREIN SANTEN PHARMACEUTICAL CO LTD (JP) 2011-06-15 EP claimed
US-7544703-B2 Cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein SANTEN PHARMACEUTICAL CO., LTD. (JP) 2009-06-09 US claimed